Rapid regression of disc and retinal neovascularization in a case of Eales disease after intravitreal bevacizumab.
Kumar
Atul
A
Sinha
Subijay
S
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005451:Fluorescein Angiography; D006801:Humans; D007267:Injections; D008297:Male; D009898:Optic Disk / Q000098:blood supply*; D015861:Retinal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D031300:Retinal Vasculitis / Q000150:complications*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014822:Vitreous Body
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab